About
Nessan Bermingham is an operating partner at Khosla Ventures with nearly three decades of experience in life sciences. He has founded and led multiple biotech companies focused on gene editing, RNA therapeutics, and cell therapies, including Intellia Therapeutics, which went public within two years of its founding. His investment experience spans public and private equities, debt instruments, and cross-border healthcare transactions.
Experience
- Khosla VenturesOperating Partnercurrent2021 — presentCambridge, MA
- Biotechnology Innovation OrganizationVice Chair BIO Investor Councilcurrent2026 — present
- D2B3Investor & Board Membercurrent2026 — presentNew Haven, CT
- Excelsior SciencesInvestor & Board Membercurrent2025 — presentNew York, NY
- Amide TechnologiesBoard Membercurrent2025 — presentWaltham, MA
- Kamau TherapeuticsInvestor & Board Membercurrent2024 — presentSouth San Francisco, CA
- Eligo BioscienceBoard Membercurrent2024 — presentParis
- Stylus MedicineInvestor & Board Membercurrent2024 — presentCambridge, MA
- Ochre BioBoard Membercurrent2022 — presentCambridge
- Liberate BioFounder, Investor & Board Membercurrent2022 — presentCambridge, MA
- EveryONE MedicinesFounder & Board Membercurrent2022 — presentBoston, MA
- Deep GenomicsBoard Membercurrent2022 — presentToronto Canada
- Korro Bio, Inc.Founder & Exec Chaircurrent2018 — presentCambridge, MA
- F-star Therapeutics, Inc.Chairperson2018 — 2023
- Triplet TherapeuticsFounder, CEO & Exec Chair2018 — 2022
- Atlas VentureVenture Partner2018 — 2020
- Xilio Therapeutics, Inc.Exec Chair2018 — 2020
- Intellia Therapeutics, Inc.Founder, President & CEO2014 — 2017
- Atlas VentureEIR2012 — 2014
- Omega FundsPartner2007 — 2008
Education
- Baylor College of MedicinePost doctoral research - Howard Hughes Assoc Fellow1997 — 2000
- Imperial College LondonDoctor of Philosophy - PhD, Molecular Biology1993 — 1997
- Queen's University BelfastBachelor's degree, Genetics1990 — 1993
- UCLDoctor of Philosophy - PhD, Molecular Biology
Skills & more
Analytical SkillsBoard GovernanceBoard LevelFundraisingEntrepreneurshipLife SciencesPortfolio ManagementMolecular BiologyBusinessBiotechnologyFinancial AnalysisVenture Capital1
+9 more
Business FormationBiotechnology IndustryExec ChairIPOMergers & Acquisitions (M&A)FinancingsBusiness StrategyBusiness DevelopmentBusiness AnalysisFrom Nessan's professional profile.
Same school
Also attended Baylor College of Medicine13
Lucy LiuPrincipal at Longwood FundJonathan MercadoPrincipal at First Bight VenturesCollin McCollAnalyst at First Bight VenturesFarzad SoleimaniPartner at 1984 Ventures Management, LlcBibhash MukhopadhyayManaging Partner at Sound BioventuresMark AdamsPartner at Two Bear Capital
+ 7 more
Also attended Imperial College London295
Deji SasegbonVP, Platform & Portfolio Operations at EchoVC PartnersMadison LenormandInvestor at DaphniPauline BoucherInvestor at DaphniLoubaba El AyoubiInvestor at NorthzoneGiovanni MariggiInvestor at MedicxiFrancois PrinslooInvestor at Medicxi
+ 289 more
Also attended Queen's University Belfast28
Johnathan GrahamHead of Compliance at Fuel VenturesNicole StumpExecutive Assistant at Ensemble VCAndrew DryliePrincipal at Quadri VenturesJim CurranInvestment Director at Clarendon Fund Managers Ltd.Damien CallaghanChairman at Clarendon Fund Managers Ltd.Claudine OwensInvestment Manager at Clarendon Fund Managers Ltd.
+ 22 more
Shared employers
Also worked at Deep Genomics1
Also worked at F-star Therapeutics, Inc.6
Also worked at Xilio Therapeutics, Inc.6
Colleagues at Khosla Ventures
Adina Tecklu
Investor at Khosla Ventures
Adrian Radu
Investor at Khosla Ventures
Alex Morgan
Investor at Khosla Ventures
Alice Brooks
Investor at Khosla Ventures
Amy Kalokerinos
Investor at Khosla Ventures
Anne Foor
Investor at Khosla Ventures
Austin Hay
Investor at Khosla Ventures
Avisha Mehra Naganath
Investor at Khosla Ventures

































.jpeg)











